InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF) Starts Presentation at the 8th Annual LD Micro Invitational
InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF) is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed's proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the company. For more information, visit the company's website at www.InMedPharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media…







